For Immediate Release: May 25, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, the FDA updated its guidance, Emergency Use Authorization for Vaccines to …
For Immediate Release: May 21, 2021 The U.S. Food and Drug Administration announced today that U.S. Marshals, at the agency’s request, seized more than 207,000 units of dietary supplements and bulk dietary ingredients that are or contain kratom, including …
For Immediate Release: May 21, 2021 The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic: The FDA issued a reminder to health care providers to give clear, step-by-step instructions to …
For Immediate Release: May 21, 2021 Today, the U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations: …
For Immediate Release: May 20, 2021 The following quote is attributed to David Lee, M.D., director, Division of Mammography Quality Standards, Office of In Vitro Diagnostics and Radiological Health, FDA’s Center for Devices and Radiological Health “The FDA …
For Immediate Release: May 20, 2021 The following is attributed to Jeff Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health “The FDA continues to explore new approaches to promote greater safety of medical devices. Today, …
For Immediate Release: May 19, 2021 The following quote is attributed to Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research Making COVID-19 vaccines widely available is key to getting people vaccinated and bringing …
For Immediate Release: May 19, 2021 The following quote is attributed to Jeff Shuren, M.D., J.D., director of FDA’s Center for Devices and Radiological Health “As part of our commitment to help accelerate the development of innovative medical devices to …
For Immediate Release: May 19, 2021 The following quote is attributed to Tim Stenzel, M.D., Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health “The FDA is reminding the …
For Immediate Release: May 18, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On May 17, the FDA provided summary information about the status of CytoDyn, Inc …
For Immediate Release: May 18, 2021 The following quote is attributed to FDA Chief Scientist Rear Adm. Denise Hinton “I am extremely proud of the hard work and dedication of our scientists, whose expertise and creativity enable us to develop the tools and …
For Immediate Release: May 17, 2021 The following quote is attributed to Janet Woodcock, M.D., Acting FDA Commissioner “During this global pandemic, the FDA worked to protect the American public by using every tool at its disposal to quickly review and act …
For Immediate Release: May 14, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: As part of the FDA’s effort to protect consumers, on April 29, 2021 the agency …
For Immediate Release: May 13, 2021 The following quote is attributed to Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response “The FDA has been working with the CDC, state partners and Canadian officials to investigate the largest Salmonella …
For Immediate Release: May 13, 2021 The following quote is attributed to Jeff Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health “Ensuring the safety of our nation’s medical devices is a cornerstone of our consumer …
For Immediate Release: May 11, 2021 The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic: As part of the FDA’s effort to protect consumers, on May 6, 2021, the agency issued a warning letter …
For Immediate Release: November 05, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Related Information ### Boilerplate The FDA, an agency within the U.S. …
For Immediate Release: May 11, 2021 The following quote is attributed to Michael Kopcha Ph.D., R.Ph., director of the FDA’s Office of Pharmaceutical Quality “The FDA is continually working to promote drug innovation and improvement, strengthen quality …
For Immediate Release: May 10, 2021 Today, the U.S. Food and Drug Administration expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute …
For Immediate Release: May 10, 2021 The following quote is attributed to Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research “Vaccines continue to be an important public health measure in fighting the COVID-19 …
